Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

130.34
USD
+1.72
(+1.34%)
3.42EPS
22.25P/E
8.93BMarket Cap
Nov 05Next Earn

Halozyme Therapeutics, Inc. Documents

Q4 FY2022 · Presentation

Halozyme Therapeutics Inc - Q4 2022 - Conference Call Deck · 18 pages

Read Halozyme Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q4 FY2022 documents